35 related items for PubMed ID: 17670846
1. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, Labrador-Horrillo M, Vilardell-Tarrés M.
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[Abstract] [Full Text] [Related]
2. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
Zhu J, Chen Y, Chen Y, Lv Y, Chen T.
Ren Fail; 2024 Dec; 46(1):2358187. PubMed ID: 38803234
[Abstract] [Full Text] [Related]
3. Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition.
Nikolopoulos D, Parodis I.
Front Med (Lausanne); 2023 Dec; 10():1217147. PubMed ID: 37457579
[Abstract] [Full Text] [Related]
4. pSTAT1 Is Activated during the Progression of IgA Nephropathy.
Tao J, Kambham N, Kwok S, Lafayette RA.
Glomerular Dis; 2023 Dec; 3(1):12-18. PubMed ID: 36816429
[Abstract] [Full Text] [Related]
5. Urinary biomarkers in lupus nephritis.
Aragón CC, Tafúr RA, Suárez-Avellaneda A, Martínez MT, Salas AL, Tobón GJ.
J Transl Autoimmun; 2020 Dec; 3():100042. PubMed ID: 32743523
[Abstract] [Full Text] [Related]
6. Epigenetic Regulation of Innate Immunity by microRNAs.
Boosani CS, Agrawal DK.
Antibodies (Basel); 2016 Apr 01; 5(2):. PubMed ID: 31557989
[Abstract] [Full Text] [Related]
7. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A, Padjen I, Fanouriakis A, Boumpas DT.
Cells; 2019 Aug 15; 8(8):. PubMed ID: 31443172
[Abstract] [Full Text] [Related]
8. The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3.
Németh Á, Mózes MM, Calvier L, Hansmann G, Kökény G.
BMC Nephrol; 2019 Jul 05; 20(1):245. PubMed ID: 31277592
[Abstract] [Full Text] [Related]
9. Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.
Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, Nwaukoni J, Rasmussen S, Rubin M, Newman JD, Buyon JP, Berger JS.
Arterioscler Thromb Vasc Biol; 2017 Apr 05; 37(4):707-716. PubMed ID: 28153882
[Abstract] [Full Text] [Related]
10. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
Hsu TC, Chiu CC, Chang SC, Chan HC, Shi YF, Chen TY, Tzang BS.
Virulence; 2016 Apr 05; 7(2):110-8. PubMed ID: 26632342
[Abstract] [Full Text] [Related]
11. Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.
Shao WH, Gamero AM, Zhen Y, Lobue MJ, Priest SO, Albandar HJ, Cohen PL.
J Immunol; 2015 Nov 01; 195(9):4136-43. PubMed ID: 26392462
[Abstract] [Full Text] [Related]
12. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis.
Lu MC, Lai NS, Chen HC, Yu HC, Huang KY, Tung CH, Huang HB, Yu CL.
Clin Exp Immunol; 2013 Jan 01; 171(1):91-9. PubMed ID: 23199328
[Abstract] [Full Text] [Related]
13. Mechanisms of tissue injury in lupus nephritis.
Nowling TK, Gilkeson GS.
Arthritis Res Ther; 2011 Jan 01; 13(6):250. PubMed ID: 22192660
[Abstract] [Full Text] [Related]
14. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity.
Huang X, Guo Y, Bao C, Shen N.
PLoS One; 2011 Jan 01; 6(7):e21671. PubMed ID: 21799742
[Abstract] [Full Text] [Related]
15. Biomarkers for lupus nephritis: a critical appraisal.
Mok CC.
J Biomed Biotechnol; 2010 Jan 01; 2010():638413. PubMed ID: 20414362
[Abstract] [Full Text] [Related]
16. Cytokines in systemic lupus erythematosus.
Lourenço EV, La Cava A.
Curr Mol Med; 2009 Apr 01; 9(3):242-54. PubMed ID: 19355907
[Abstract] [Full Text] [Related]
17. Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.
Liang Y, Jin Y, Li Y.
Pediatr Nephrol; 2009 Sep 01; 24(9):1661-71. PubMed ID: 19350281
[Abstract] [Full Text] [Related]
18. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, Labrador-Horrillo M, Vilardell-Tarrés M.
Lupus; 2007 Sep 01; 16(7):483-8. PubMed ID: 17670846
[Abstract] [Full Text] [Related]
19. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata H.
Arthritis Rheum; 2001 Sep 01; 44(9):2097-106. PubMed ID: 11592372
[Abstract] [Full Text] [Related]
20. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T, Masaki T, Hirai T, Doi S, Kuratsune M, Arihiro K, Kohno N, Yorioka N.
Nephrol Dial Transplant; 2008 Nov 01; 23(11):3418-26. PubMed ID: 18556750
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
